3M (NYSE:MMM) and Delcath Systems (OTCMKTS:DCTH) are both multi-sector conglomerates companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.
Insider & Institutional Ownership
66.7% of 3M shares are held by institutional investors. 0.8% of 3M shares are held by insiders. Comparatively, 0.0% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
This table compares 3M and Delcath Systems’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|3M||$32.77 billion||2.93||$5.35 billion||$10.46||15.94|
|Delcath Systems||$2.71 million||0.80||-$45.11 million||N/A||N/A|
3M has higher revenue and earnings than Delcath Systems.
Volatility and Risk
3M has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500.
3M pays an annual dividend of $5.76 per share and has a dividend yield of 3.5%. Delcath Systems does not pay a dividend. 3M pays out 55.1% of its earnings in the form of a dividend. 3M has raised its dividend for 60 consecutive years.
This is a breakdown of recent recommendations and price targets for 3M and Delcath Systems, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
3M currently has a consensus price target of $190.18, suggesting a potential upside of 14.09%. Given 3M’s higher possible upside, equities research analysts clearly believe 3M is more favorable than Delcath Systems.
This table compares 3M and Delcath Systems’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
3M beats Delcath Systems on 13 of the 14 factors compared between the two stocks.
3M Company Profile
3M Company operates as a technology company worldwide. The company's Industrial segment offers tapes, abrasives, adhesives, ceramics, sealants, specialty materials, purification products, closure systems, acoustic systems products, automotive components, abrasion-resistant films, and paint finishing and detailing products. Its Safety and Graphics segment provides personal protection and transportation safety products, commercial graphics systems, commercial cleaning and protection products, floor matting, roofing granules, fall protection products, self-contained breathing apparatus systems, and gas and flame detection instruments. The company's Health Care segment offers medical and surgical supplies, skin health and infection prevention products, drug delivery and health information systems, dental and orthodontic products, and food safety products. Its Electronics and Energy segment provides optical films, packaging and interconnection devices, insulating and splicing solutions, touch screens and monitors, renewable energy component solutions, and infrastructure protection products. The company's Consumer segment offers consumer and office tapes and adhesives, repositionable notes, indexing systems, home improvement products, furnace filters, painter tapes, mounting and home care products, sponges, scouring pads, high-performance clothes, protective material products, and adhesive bandages and braces. It also provides cloud-based, conversational artificial intelligence-powered systems. It serves automotive, electronics and automotive electrification, appliance, paper and printing, packaging, food and beverage, construction, medical clinics and hospitals, pharmaceuticals, dental and orthodontic practitioners, health information systems, food manufacturing and testing, consumer and office retail, office business to business, home improvement, drug and pharmacy retail, and other markets. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Delcath Systems Company Profile
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company is developing melphalan hydrochloride for Injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. It offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York.
Receive News & Ratings for 3M Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3M and related companies with MarketBeat.com's FREE daily email newsletter.